Korro Bio Inc KRRO
News
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
Korro to Participate in Upcoming Investor Conferences
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
Korro to Participate in Upcoming September Investor and Scientific Conferences
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates